| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9261578 | Autoimmunity Reviews | 2005 | 9 Pages |
Abstract
We here review the current and prospective roles of infliximab in the treatment of autoimmune diseases and other conditions that do not currently have FDA or EMEA approval.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Andrea Doria, Luca Iaccarino, Franco Capsoni,